BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 024567
(265 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3RGF|B Chain B, Crystal Structure Of Human Cdk8CYCC
Length = 285
Score = 155 bits (392), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 88/230 (38%), Positives = 138/230 (60%), Gaps = 18/230 (7%)
Query: 51 RRTTNSFWTKKTWM-W----RNLLTEKRASLLKITSS----LRCRCPTIYRNLAQHVKVR 101
+ +FW ++ W ++LL E++ L ++ L+ + + L +H+K+R
Sbjct: 1 KAMAGNFWQSSHYLQWILDKQDLLKERQKDLKFLSEEEYWKLQIFFTNVIQALGEHLKLR 60
Query: 102 QRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLASKAEESTV--QARLL-----VFYI 154
Q+V+ATA Y +R Y R S+ DP L+APTC++LASK EE V RL+ V
Sbjct: 61 QQVIATATVYFKRFYARYSLKSIDPVLMAPTCVFLASKVEEFGVVSNTRLIAAATSVLKT 120
Query: 155 KKIYSDEK-YRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFLQDAGMNDINMTHLSW 213
+ Y+ K + Y + ILE E +LE ++ L+V+HPYR L+Q++QD G D+ + L+W
Sbjct: 121 RFSYAFPKEFPYRMNHILECEFYLLELMDCCLIVYHPYRPLLQYVQDMGQEDM-LLPLAW 179
Query: 214 GILNDTYKMDLILVHPPHLIALACIYIASVYREKDNTAWFEELRVDMNVV 263
I+NDTY+ DL L++PP +IALAC+++A V ++KD WF EL VDM +
Sbjct: 180 RIVNDTYRTDLCLLYPPFMIALACLHVACVVQQKDARQWFAELSVDMEKI 229
>pdb|1ZP2|A Chain A, Structure Of The Mediator Subunit Cyclin C
Length = 235
Score = 84.3 bits (207), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 49/159 (30%), Positives = 84/159 (52%), Gaps = 3/159 (1%)
Query: 90 IYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTE-YDPHLVAPTCLYLASKAEESTVQAR 148
+ + +++RQRV+ATA+ +RR +K+ + + + TC+YL+ K EE V R
Sbjct: 34 VVQTFGDRLRLRQRVLATAIVLLRRYMLKKNEEKGFSLEALVATCIYLSCKVEECPVHIR 93
Query: 149 LLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFLQDAGMNDINM 208
+ ++S K + +I E+E +I+ L+ +L+V HPY SL Q D +N +
Sbjct: 94 TICNEANDLWS-LKVKLSRSNISEIEFEIISVLDAFLIVHHPYTSLEQAFHDGIINQKQL 152
Query: 209 THLSWGILNDTYKMDLILVHPPHLIALACIYIASVYREK 247
+W I+ND+Y L L+ PH +A A + I+ E
Sbjct: 153 -EFAWSIVNDSYASSLCLMAHPHQLAYAALLISCCNDEN 190
>pdb|3TNH|B Chain B, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|B Chain B, Structure Of Cdk9CYCLIN T F241L
Length = 259
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 48/173 (27%), Positives = 84/173 (48%), Gaps = 17/173 (9%)
Query: 82 SLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLASKAE 141
S R + + +++ Q + V Q + TA+ YM R Y +S T++ + VAP L+LA+K E
Sbjct: 36 SYRQQAANLLQDMGQRLNVSQLTINTAIVYMHRFYMIQSFTQFPGNSVAPAALFLAAKVE 95
Query: 142 ESTVQARLLVFYIKKIYS------------DEKYRYEVKDILEMEMKILEALNYYLVVFH 189
E Q + L IK ++ E Y +V+D++ +E IL+ L + L + H
Sbjct: 96 E---QPKKLEHVIKVAHTCLHPQESLPDTRSEAYLQQVQDLVILESIILQTLGFELTIDH 152
Query: 190 PYRSLVQFLQDA-GMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
P+ +V+ Q D+ T + N + L + P ++A CI++A
Sbjct: 153 PHTHVVKCTQLVRASKDLAQTSY-FMATNSLHLTTFSLQYTPPVVACVCIHLA 204
>pdb|3MI9|B Chain B, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|B Chain B, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 266
Score = 66.6 bits (161), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 48/173 (27%), Positives = 84/173 (48%), Gaps = 17/173 (9%)
Query: 82 SLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLASKAE 141
S R + + +++ Q + V Q + TA+ YM R Y +S T++ + VAP L+LA+K E
Sbjct: 36 SYRQQAANLLQDMGQRLNVSQLTINTAIVYMHRFYMIQSFTQFPGNSVAPAALFLAAKVE 95
Query: 142 ESTVQARLLVFYIKKIYS------------DEKYRYEVKDILEMEMKILEALNYYLVVFH 189
E Q + L IK ++ E Y +V+D++ +E IL+ L + L + H
Sbjct: 96 E---QPKKLEHVIKVAHTCLHPQESLPDTRSEAYLQQVQDLVILESIILQTLGFELTIDH 152
Query: 190 PYRSLVQFLQDA-GMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
P+ +V+ Q D+ T + N + L + P ++A CI++A
Sbjct: 153 PHTHVVKCTQLVRASKDLAQTSY-FMATNSLHLTTFSLQYTPPVVACVCIHLA 204
>pdb|2PK2|A Chain A, Cyclin Box Structure Of The P-Tefb Subunit Cyclin T1
Derived From A Fusion Complex With Eiav Tat
pdb|2PK2|B Chain B, Cyclin Box Structure Of The P-Tefb Subunit Cyclin T1
Derived From A Fusion Complex With Eiav Tat
pdb|2PK2|C Chain C, Cyclin Box Structure Of The P-Tefb Subunit Cyclin T1
Derived From A Fusion Complex With Eiav Tat
pdb|2PK2|D Chain D, Cyclin Box Structure Of The P-Tefb Subunit Cyclin T1
Derived From A Fusion Complex With Eiav Tat
Length = 358
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 17/208 (8%)
Query: 47 ISGHRRTTNSFWTKKTWMWRNLLTEKRASLLKITSSLRCRCPTIYRNLAQHVKVRQRVVA 106
+ G R+ N W N + + S R + + +++ Q + V Q +
Sbjct: 1 MEGERKNNNKRWYFTREQLENSPSRRFGVDPDKELSYRQQAANLLQDMGQRLNVSQLTIN 60
Query: 107 TAVTYMRRCYTRKSMTEYDPHLVAPTCLYLASKAEESTVQARLLVFYIKKIYS------- 159
TA+ YM R Y +S T + + VAP L+LA+K EE Q + L IK ++
Sbjct: 61 TAIVYMHRFYMIQSFTRFPGNSVAPAALFLAAKVEE---QPKKLEHVIKVAHTCLHPQES 117
Query: 160 -----DEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFLQDA-GMNDINMTHLSW 213
E Y +V+D++ +E IL+ L + L + HP+ +V+ Q D+ T +
Sbjct: 118 LPDTRSEAYLQQVQDLVILESIILQTLGFELTIDHPHTHVVKCTQLVRASKDLAQTSY-F 176
Query: 214 GILNDTYKMDLILVHPPHLIALACIYIA 241
N + L + P ++A CI++A
Sbjct: 177 MATNSLHLTTFSLQYTPPVVACVCIHLA 204
>pdb|2W2H|A Chain A, Structural Basis Of Transcription Activation By The Cyclin
T1-Tat-Tar Rna Complex From Eiav
pdb|2W2H|B Chain B, Structural Basis Of Transcription Activation By The Cyclin
T1-Tat-Tar Rna Complex From Eiav
Length = 264
Score = 65.5 bits (158), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 48/173 (27%), Positives = 83/173 (47%), Gaps = 17/173 (9%)
Query: 82 SLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLASKAE 141
S R + + +++ Q + V Q + TA+ YM R Y +S T + + VAP L+LA+K E
Sbjct: 33 SYRQQAANLLQDMGQRLNVSQLTINTAIVYMHRFYMIQSFTRFHRNSVAPAALFLAAKVE 92
Query: 142 ESTVQARLLVFYIKKIYS------------DEKYRYEVKDILEMEMKILEALNYYLVVFH 189
E Q + L IK ++ E Y +V+D++ +E IL+ L + L + H
Sbjct: 93 E---QPKKLEHVIKVAHTCLHPQESLPDTRSEAYLQQVQDLVILESIILQTLGFELTIDH 149
Query: 190 PYRSLVQFLQDA-GMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
P+ +V+ Q D+ T + N + L + P ++A CI++A
Sbjct: 150 PHTHVVKCTQLVRASKDLAQTSY-FMATNSLHLTTFSLQYTPPVVACVCIHLA 201
>pdb|3BLH|B Chain B, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|B Chain B, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|B Chain B, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|B Chain B, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|B Chain B, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|B Chain B, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|4EC8|B Chain B, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|B Chain B, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
pdb|4BCF|B Chain B, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCH|B Chain B, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|B Chain B, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|B Chain B, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 260
Score = 64.3 bits (155), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 11/170 (6%)
Query: 82 SLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLASKAE 141
S R + + +++ Q + V Q + TA+ YM R Y +S T + + VAP L+LA+K E
Sbjct: 37 SYRQQAANLLQDMGQRLNVSQLTINTAIVYMHRFYMIQSFTRFPGNSVAPAALFLAAKVE 96
Query: 142 ------ESTVQARLLVFYIKKIYSD---EKYRYEVKDILEMEMKILEALNYYLVVFHPYR 192
E ++ + ++ D E Y +V+D++ +E IL+ L + L + HP+
Sbjct: 97 GQPKKLEHVIKVAHTCLHPQESLPDTRSEAYLQQVQDLVILESIILQTLGFELTIDHPHT 156
Query: 193 SLVQFLQDA-GMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
+V+ Q D+ T + N + L + P ++A CI++A
Sbjct: 157 HVVKCTQLVRASKDLAQTSY-FMATNSLHLTTFSLQYTPPVVACVCIHLA 205
>pdb|1KXU|A Chain A, Cyclin H, A Positive Regulatory Subunit Of Cdk Activating
Kinase
Length = 333
Score = 63.5 bits (153), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 44/141 (31%), Positives = 68/141 (48%), Gaps = 8/141 (5%)
Query: 104 VVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLASKAEESTVQARLLVFYIKKIYSDEKY 163
VV TA Y +R Y S+ EY P ++ TC +LA K +E V + V +++ S
Sbjct: 89 VVGTACMYFKRFYLNNSVMEYHPRIIMLTCAFLACKVDEFNVSSPQFVGNLRE--SPLGQ 146
Query: 164 RYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFLQDAGM------NDINMTHLSWGILN 217
++ ILE E+ +++ LN++L+V +PYR FL D N + + LN
Sbjct: 147 EKALEQILEYELLLIQQLNFHLIVHNPYRPFEGFLIDLKTRYPILENPEILRKTADDFLN 206
Query: 218 DTYKMDLILVHPPHLIALACI 238
D L++ P IAL I
Sbjct: 207 RIALTDAYLLYTPSQIALTAI 227
>pdb|1JKW|A Chain A, Structure Of Cyclin Mcs2
Length = 323
Score = 63.5 bits (153), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 44/141 (31%), Positives = 68/141 (48%), Gaps = 8/141 (5%)
Query: 104 VVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLASKAEESTVQARLLVFYIKKIYSDEKY 163
VV TA Y +R Y S+ EY P ++ TC +LA K +E V + V +++ S
Sbjct: 79 VVGTACMYFKRFYLNNSVMEYHPRIIMLTCAFLACKVDEFNVSSPQFVGNLRE--SPLGQ 136
Query: 164 RYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFLQDAGM------NDINMTHLSWGILN 217
++ ILE E+ +++ LN++L+V +PYR FL D N + + LN
Sbjct: 137 EKALEQILEYELLLIQQLNFHLIVHNPYRPFEGFLIDLKTRYPILENPEILRKTADDFLN 196
Query: 218 DTYKMDLILVHPPHLIALACI 238
D L++ P IAL I
Sbjct: 197 RIALTDAYLLYTPSQIALTAI 217
>pdb|2IVX|A Chain A, Crystal Structure Of Human Cyclin T2 At 1.8 A Resolution
(Casp Target)
pdb|2IVX|B Chain B, Crystal Structure Of Human Cyclin T2 At 1.8 A Resolution
(Casp Target)
Length = 257
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 46/173 (26%), Positives = 85/173 (49%), Gaps = 17/173 (9%)
Query: 82 SLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLASKAE 141
S R + + + + Q + V Q + TA+ YM R Y S T+++ ++++ T L+LA+K E
Sbjct: 29 SCRQQAANLIQEMGQRLNVSQLTINTAIVYMHRFYMHHSFTKFNKNIISSTALFLAAKVE 88
Query: 142 ESTVQARLLVFYIKKIYS---------DEK---YRYEVKDILEMEMKILEALNYYLVVFH 189
E QAR L IK ++ D K Y + ++++ +E +L+ L + + + H
Sbjct: 89 E---QARKLEHVIKVAHACLHPLEPLLDTKCDAYLQQTRELVILETIMLQTLGFEITIEH 145
Query: 190 PYRSLVQFLQDA-GMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
P+ +V+ Q D+ T + N + L + P +IA CI++A
Sbjct: 146 PHTDVVKCTQLVRASKDLAQTSY-FMATNSLHLTTFCLQYKPTVIACVCIHLA 197
>pdb|2I53|A Chain A, Crystal Structure Of Cyclin K
Length = 258
Score = 61.6 bits (148), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 36/145 (24%), Positives = 74/145 (51%), Gaps = 7/145 (4%)
Query: 105 VATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLASKAEESTVQARLLVFYIKKIYSDEKYR 164
+AT + Y R Y S ++ ++ CL+LA K EE+ + + ++ + + +D ++
Sbjct: 62 LATGIIYFHRFYMFHSFKQFPRYVTGACCLFLAGKVEETPKKCKDIIKTARSLLNDVQFG 121
Query: 165 YEVKD----ILEMEMKILEALNYYLVVFHPYRSLVQFLQD--AGMNDIN-MTHLSWGILN 217
D ++ +E +L+ + + L V HPY+ L+++ + N I + ++W +N
Sbjct: 122 QFGDDPKEEVMVLERILLQTIKFDLQVEHPYQFLLKYAKQLKGDKNKIQKLVQMAWTFVN 181
Query: 218 DTYKMDLILVHPPHLIALACIYIAS 242
D+ L L P +IA+A +Y+A
Sbjct: 182 DSLCTTLSLQWEPEIIAVAVMYLAG 206
>pdb|2B9R|A Chain A, Crystal Structure Of Human Cyclin B1
pdb|2B9R|B Chain B, Crystal Structure Of Human Cyclin B1
Length = 269
Score = 34.7 bits (78), Expect = 0.062, Method: Compositional matrix adjust.
Identities = 47/185 (25%), Positives = 78/185 (42%), Gaps = 19/185 (10%)
Query: 78 KITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLA 137
++T ++R + ++ Q + V+ + R S+ + LV T +++A
Sbjct: 32 EVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNSVPKKMLQLVGVTAMFIA 91
Query: 138 SKAEES-TVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQ 196
SK EE + F Y+ + R +MEMKIL ALN+ L P +
Sbjct: 92 SKYEEMYPPEIGDFAFVTDNTYTKHQIR-------QMEMKILRALNFGLGRPLP----LH 140
Query: 197 FLQDA---GMNDINMTHLSWGILNDTYKMDLILVH-PPHLIALACIYIASVYREKDNTAW 252
FL+ A G D+ L+ ++ T +D +VH PP IA +A + DN W
Sbjct: 141 FLRRASKIGEVDVEQHTLAKYLMELTM-LDYDMVHFPPSQIAAGAFSLA--LKILDNGEW 197
Query: 253 FEELR 257
L+
Sbjct: 198 TPTLQ 202
>pdb|2JGZ|B Chain B, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 260
Score = 32.7 bits (73), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 41/136 (30%), Positives = 60/136 (44%), Gaps = 19/136 (13%)
Query: 127 HLVAPTCLYLASKAEES-TVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYL 185
LV T +++ASK EE + F Y+ + R +MEMKIL ALN+ L
Sbjct: 79 QLVGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIR-------QMEMKILRALNFGL 131
Query: 186 VVFHPYRSLVQFLQDA---GMNDINMTHLSWGILNDTYKMDLILVH-PPHLIALACIYIA 241
P + FL+ A G D+ L+ ++ T +D +VH PP IA +A
Sbjct: 132 GRPLP----LHFLRRASKIGEVDVEQHTLAKYLMELTM-LDYDMVHFPPSQIAAGAFCLA 186
Query: 242 SVYREKDNTAWFEELR 257
+ DN W L+
Sbjct: 187 --LKILDNGEWTPTLQ 200
>pdb|4BCQ|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 30.0 bits (66), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 9/165 (5%)
Query: 79 ITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLAS 138
IT+S+R + + K++ + AV Y+ R + S+ LV + LAS
Sbjct: 36 ITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 95
Query: 139 KAEESTVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFL 198
K EE YI +D+ Y K +L ME +L+ L + L + L Q+
Sbjct: 96 KFEEIYPPEVAEFVYI----TDDTYTK--KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYF 149
Query: 199 --QDAGMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
Q + + G L+ D L + P +IA A ++A
Sbjct: 150 LHQQPANCKVESLAMFLGELS-LIDADPYLKYLPSVIAAAAFHLA 193
>pdb|4BCQ|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 30.0 bits (66), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 9/165 (5%)
Query: 79 ITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLAS 138
IT+S+R + + K++ + AV Y+ R + S+ LV + LAS
Sbjct: 36 ITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 95
Query: 139 KAEESTVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFL 198
K EE YI +D+ Y K +L ME +L+ L + L + L Q+
Sbjct: 96 KFEEIYPPEVAEFVYI----TDDTYTK--KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYF 149
Query: 199 --QDAGMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
Q + + G L+ D L + P +IA A ++A
Sbjct: 150 LHQQPANCKVESLAMFLGELS-LIDADPYLKYLPSVIAAAAFHLA 193
>pdb|1VYW|B Chain B, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|D Chain D, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|B Chain B, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|D Chain D, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|B Chain B, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|D Chain D, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|B Chain B, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|D Chain D, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|B Chain B, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|D Chain D, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|B Chain B, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|D Chain D, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|B Chain B, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|D Chain D, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|B Chain B, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|D Chain D, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 265
Score = 30.0 bits (66), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 9/165 (5%)
Query: 79 ITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLAS 138
IT+S+R + + K++ + AV Y+ R + S+ LV + LAS
Sbjct: 39 ITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 98
Query: 139 KAEESTVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFL 198
K EE YI +D+ Y K +L ME +L+ L + L + L Q+
Sbjct: 99 KFEEIYPPEVAEFVYI----TDDTYTK--KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYF 152
Query: 199 --QDAGMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
Q + + G L+ D L + P +IA A ++A
Sbjct: 153 LHQQPANCKVESLAMFLGELS-LIDADPYLKYLPSVIAGAAFHLA 196
>pdb|4BCO|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 30.0 bits (66), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 9/165 (5%)
Query: 79 ITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLAS 138
IT+S+R + + K++ + AV Y+ R + S+ LV + LAS
Sbjct: 36 ITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 95
Query: 139 KAEESTVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFL 198
K EE YI +D+ Y K +L ME +L+ L + L + L Q+
Sbjct: 96 KFEEIYPPEVAEFVYI----TDDTYTK--KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYF 149
Query: 199 --QDAGMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
Q + + G L+ D L + P +IA A ++A
Sbjct: 150 LHQQPANCKVESLAMFLGELS-LIDADPYLKYLPSVIAAAAFHLA 193
>pdb|3F5X|B Chain B, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|D Chain D, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
Length = 256
Score = 29.6 bits (65), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 9/165 (5%)
Query: 79 ITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLAS 138
IT+S+R + + K++ + AV Y+ R + S+ LV + LAS
Sbjct: 30 ITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 89
Query: 139 KAEESTVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFL 198
K EE YI +D+ Y K +L ME +L+ L + L + L Q+
Sbjct: 90 KFEEIYPPEVAEFVYI----TDDTYTK--KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYF 143
Query: 199 --QDAGMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
Q + + G L+ D L + P +IA A ++A
Sbjct: 144 LHQQPANCKVESLAMFLGELS-LIDADPYLKYLPSVIAGAAFHLA 187
>pdb|1FIN|B Chain B, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|D Chain D, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1JSU|B Chain B, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FVV|B Chain B, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|D Chain D, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1OKV|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|B Chain B, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|D Chain D, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|B Chain B, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|D Chain D, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1URC|B Chain B, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|D Chain D, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|2C5O|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2CCH|B Chain B, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|D Chain D, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2I40|B Chain B, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|D Chain D, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|3EID|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|B Chain B, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|D Chain D, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2WEV|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
Length = 260
Score = 29.6 bits (65), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 9/165 (5%)
Query: 79 ITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLAS 138
IT+S+R + + K++ + AV Y+ R + S+ LV + LAS
Sbjct: 34 ITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 93
Query: 139 KAEESTVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFL 198
K EE YI +D+ Y K +L ME +L+ L + L + L Q+
Sbjct: 94 KFEEIYPPEVAEFVYI----TDDTYTK--KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYF 147
Query: 199 --QDAGMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
Q + + G L+ D L + P +IA A ++A
Sbjct: 148 LHQQPANCKVESLAMFLGELS-LIDADPYLKYLPSVIAGAAFHLA 191
>pdb|2X1N|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
Length = 261
Score = 29.6 bits (65), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 9/165 (5%)
Query: 79 ITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLAS 138
IT+S+R + + K++ + AV Y+ R + S+ LV + LAS
Sbjct: 35 ITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 94
Query: 139 KAEESTVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFL 198
K EE YI +D+ Y K +L ME +L+ L + L + L Q+
Sbjct: 95 KFEEIYPPEVAEFVYI----TDDTYTK--KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYF 148
Query: 199 --QDAGMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
Q + + G L+ D L + P +IA A ++A
Sbjct: 149 LHQQPANCKVESLAMFLGELS-LIDADPYLKYLPSVIAGAAFHLA 192
>pdb|1QMZ|B Chain B, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|D Chain D, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1H24|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|B Chain B, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|D Chain D, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2C5N|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2UUE|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2WMA|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 259
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 9/165 (5%)
Query: 79 ITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLAS 138
IT+S+R + + K++ + AV Y+ R + S+ LV + LAS
Sbjct: 33 ITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 92
Query: 139 KAEESTVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFL 198
K EE YI +D+ Y K +L ME +L+ L + L + L Q+
Sbjct: 93 KFEEIYPPEVAEFVYI----TDDTYTK--KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYF 146
Query: 199 --QDAGMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
Q + + G L+ D L + P +IA A ++A
Sbjct: 147 LHQQPANCKVESLAMFLGELS-LIDADPYLKYLPSVIAGAAFHLA 190
>pdb|1OGU|B Chain B, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|D Chain D, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|2IW6|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW8|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW9|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 260
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 9/165 (5%)
Query: 79 ITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLAS 138
IT+S+R + + K++ + AV Y+ R + S+ LV + LAS
Sbjct: 34 ITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 93
Query: 139 KAEESTVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFL 198
K EE YI +D+ Y K +L ME +L+ L + L + L Q+
Sbjct: 94 KFEEIYPPEVAEFVYI----TDDTYTK--KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYF 147
Query: 199 --QDAGMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
Q + + G L+ D L + P +IA A ++A
Sbjct: 148 LHQQPANCKVESLAMFLGELS-LIDADPYLKYLPSVIAGAAFHLA 191
>pdb|1E9H|B Chain B, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|D Chain D, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
Length = 261
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 29/107 (27%), Positives = 46/107 (42%), Gaps = 6/107 (5%)
Query: 79 ITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLAS 138
IT+S+R + + K++ + AV Y+ R + S+ LV + LAS
Sbjct: 32 ITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 91
Query: 139 KAEESTVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYL 185
K EE YI +D+ Y K +L ME +L+ L + L
Sbjct: 92 KFEEIYPPEVAEFVYI----TDDTYTK--KQVLRMEHLVLKVLTFDL 132
>pdb|1JST|B Chain B, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|D Chain D, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1GY3|B Chain B, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|D Chain D, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1H1P|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1P5E|B Chain B, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|D Chain D, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1PKD|B Chain B, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|D Chain D, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|2C6T|B Chain B, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|D Chain D, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|B Chain B, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|D Chain D, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CCI|B Chain B, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|D Chain D, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2UZB|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4EOI|B Chain B, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|D Chain D, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOJ|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOK|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOM|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EON|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOO|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOP|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOQ|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOR|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOS|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 258
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 9/165 (5%)
Query: 79 ITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLAS 138
IT+S+R + + K++ + AV Y+ R + S+ LV + LAS
Sbjct: 32 ITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 91
Query: 139 KAEESTVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFL 198
K EE YI +D+ Y K +L ME +L+ L + L + L Q+
Sbjct: 92 KFEEIYPPEVAEFVYI----TDDTYTK--KQVLRMEHLVLKVLTFDLAAPTVNQFLTQYF 145
Query: 199 --QDAGMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
Q + + G L+ D L + P +IA A ++A
Sbjct: 146 LHQQPANCKVESLAMFLGELS-LIDADPYLKYLPSVIAGAAFHLA 189
>pdb|2G9X|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
Length = 262
Score = 29.3 bits (64), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 9/165 (5%)
Query: 79 ITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLAS 138
IT+S+R + + K++ + AV Y+ R + S+ LV + LAS
Sbjct: 36 ITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 95
Query: 139 KAEESTVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFL 198
K EE YI +D+ Y K +L ME +L+ L + L + L Q+
Sbjct: 96 KFEEIYPPEVAEFVYI----TDDTYTK--KQVLRMEHLVLKVLAFDLAAPTINQFLTQYF 149
Query: 199 --QDAGMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
Q + + G L+ D L + P +IA A ++A
Sbjct: 150 LHQQPANCKVESLAMFLGELS-LIDADPYLKYLPSVIAAAAFHLA 193
>pdb|1VIN|A Chain A, Bovine Cyclin A3
Length = 268
Score = 29.3 bits (64), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 9/165 (5%)
Query: 79 ITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLAS 138
IT+S+R + + K++ + AV Y+ R + S+ LV + LAS
Sbjct: 36 ITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 95
Query: 139 KAEESTVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFL 198
K EE YI +D+ Y K +L ME +L+ L + L + L Q+
Sbjct: 96 KFEEIYPPEVAEFVYI----TDDTYTK--KQVLRMEHLVLKVLAFDLAAPTINQFLTQYF 149
Query: 199 --QDAGMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
Q + + G L+ D L + P +IA A ++A
Sbjct: 150 LHQQPANCKVESLAMFLGELS-LIDADPYLKYLPSVIAAAAFHLA 193
>pdb|3DDQ|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
Length = 269
Score = 29.3 bits (64), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 9/165 (5%)
Query: 79 ITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLAS 138
IT+S+R + + K++ + AV Y+ R + S+ LV + LAS
Sbjct: 36 ITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 95
Query: 139 KAEESTVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFL 198
K EE YI +D+ Y K +L ME +L+ L + L + L Q+
Sbjct: 96 KFEEIYPPEVAEFVYI----TDDTYTK--KQVLRMEHLVLKVLAFDLAAPTINQFLTQYF 149
Query: 199 --QDAGMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
Q + + G L+ D L + P +IA A ++A
Sbjct: 150 LHQQPANCKVESLAMFLGELS-LIDADPYLKYLPSVIAAAAFHLA 193
>pdb|3DDP|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
Length = 268
Score = 29.3 bits (64), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 9/165 (5%)
Query: 79 ITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLAS 138
IT+S+R + + K++ + AV Y+ R + S+ LV + LAS
Sbjct: 36 ITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 95
Query: 139 KAEESTVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFL 198
K EE YI +D+ Y K +L ME +L+ L + L + L Q+
Sbjct: 96 KFEEIYPPEVAEFVYI----TDDTYTK--KQVLRMEHLVLKVLAFDLAAPTINQFLTQYF 149
Query: 199 --QDAGMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
Q + + G L+ D L + P +IA A ++A
Sbjct: 150 LHQQPANCKVESLAMFLGELS-LIDADPYLKYLPSVIAAAAFHLA 193
>pdb|3BHT|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|B Chain B, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|D Chain D, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|B Chain B, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|D Chain D, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
Length = 262
Score = 29.3 bits (64), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 9/165 (5%)
Query: 79 ITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLAS 138
IT+S+R + + K++ + AV Y+ R + S+ LV + LAS
Sbjct: 36 ITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 95
Query: 139 KAEESTVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFL 198
K EE YI +D+ Y K +L ME +L+ L + L + L Q+
Sbjct: 96 KFEEIYPPEVAEFVYI----TDDTYTK--KQVLRMEHLVLKVLAFDLAAPTINQFLTQYF 149
Query: 199 --QDAGMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
Q + + G L+ D L + P +IA A ++A
Sbjct: 150 LHQQPANCKVESLAMFLGELS-LIDADPYLKYLPSVIAAAAFHLA 193
>pdb|3QHR|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 261
Score = 29.3 bits (64), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 11/166 (6%)
Query: 79 ITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLAS 138
IT+S+R + + K++ + AV Y+ R + S+ LV + LAS
Sbjct: 35 ITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 94
Query: 139 KAEESTVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQF- 197
K EE YI +D+ Y K +L ME +L+ L + L + L Q+
Sbjct: 95 KFEEIYPPEVAEFVYI----TDDTYSK--KQVLRMEHLVLKVLAFDLAAPTVNQFLTQYF 148
Query: 198 --LQDAGMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
LQ A + + G L+ D L + P LIA A ++A
Sbjct: 149 LHLQPANCK-VESLAMFLGELS-LIDADPYLKYLPSLIAGAAFHLA 192
>pdb|4I3Z|B Chain B, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|D Chain D, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 257
Score = 29.3 bits (64), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 11/166 (6%)
Query: 79 ITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLAS 138
IT+S+R + + K++ + AV Y+ R + S+ LV + LAS
Sbjct: 32 ITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 91
Query: 139 KAEESTVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQF- 197
K EE YI +D+ Y K +L ME +L+ L + L + L Q+
Sbjct: 92 KFEEIYPPEVAEFVYI----TDDTYSK--KQVLRMEHLVLKVLAFDLAAPTVNQFLTQYF 145
Query: 198 --LQDAGMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
LQ A + + G L+ D L + P LIA A ++A
Sbjct: 146 LHLQPANCK-VESLAMFLGELS-LIDADPYLKYLPSLIAGAAFHLA 189
>pdb|3DOG|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 264
Score = 29.3 bits (64), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 9/165 (5%)
Query: 79 ITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLAS 138
IT+S+R + + K++ + AV Y+ R + S+ LV + LAS
Sbjct: 36 ITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 95
Query: 139 KAEESTVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQFL 198
K EE YI +D+ Y K +L ME +L+ L + L + L Q+
Sbjct: 96 KFEEIYPPEVAEFVYI----TDDTYTK--KQVLRMEHLVLKVLAFDLAAPTINQFLTQYF 149
Query: 199 --QDAGMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
Q + + G L+ D L + P +IA A ++A
Sbjct: 150 LHQQPANCKVESLAMFLGELS-LIDADPYLKYLPSVIAAAAFHLA 193
>pdb|4II5|B Chain B, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|D Chain D, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 258
Score = 28.9 bits (63), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 11/166 (6%)
Query: 79 ITSSLRCRCPTIYRNLAQHVKVRQRVVATAVTYMRRCYTRKSMTEYDPHLVAPTCLYLAS 138
IT+S+R + + K++ + AV Y+ R + S+ LV + LAS
Sbjct: 32 ITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQLVGTAAMLLAS 91
Query: 139 KAEESTVQARLLVFYIKKIYSDEKYRYEVKDILEMEMKILEALNYYLVVFHPYRSLVQF- 197
K EE YI +D+ Y K +L ME +L+ L + L + L Q+
Sbjct: 92 KFEEIYPPEVAEFVYI----TDDTYSK--KQVLRMEHLVLKVLAFDLAAPTVNQFLTQYF 145
Query: 198 --LQDAGMNDINMTHLSWGILNDTYKMDLILVHPPHLIALACIYIA 241
LQ A + + G L+ D L + P LIA A ++A
Sbjct: 146 LHLQPANCK-VESLAMFLGELS-LIDADPYLKYLPSLIAGAAFHLA 189
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.323 0.135 0.414
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 7,799,229
Number of Sequences: 62578
Number of extensions: 298164
Number of successful extensions: 627
Number of sequences better than 100.0: 36
Number of HSP's better than 100.0 without gapping: 33
Number of HSP's successfully gapped in prelim test: 3
Number of HSP's that attempted gapping in prelim test: 573
Number of HSP's gapped (non-prelim): 44
length of query: 265
length of database: 14,973,337
effective HSP length: 97
effective length of query: 168
effective length of database: 8,903,271
effective search space: 1495749528
effective search space used: 1495749528
T: 11
A: 40
X1: 16 ( 7.5 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (22.0 bits)
S2: 50 (23.9 bits)